Inventor
XIAOXIA SHENG
Inventor
CN
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Bprimary
C07BGeneral methods of organic chemistry27%
C07DHeterocyclic compounds23%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07CAcyclic or carbocyclic compounds10%
Y02PClimate change mitigation technologies in the production or processing of goods3%
PatentTitleYear
12,103,925Crystal and amorphous form of tolebrutinib, preparation method therefor, and use thereof202411,919,906Crystal form of ACP-196 and method of treatment thereof202411,639,341Crystal form of tipifarnib and method of treatment thereof202311,427,528Fenofibrate crystalline form and manufacturing method thereof202211,286,259Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereof202211,236,077Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof202211,236,073ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof202211,208,382Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to HANGZHOU SOLIPHARMA CO LTD (8)· patent assignee history
2021–2024Based in CN· patent location history
2022Patents assigned to UNIV ZHEJIANG TECHNOLOGY (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HANGZHOU SOLIPHARMA CO LTD | 8 | 2021–2024 |
| UNIV ZHEJIANG TECHNOLOGY | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 8 | 2021–2024 |